Dow Jones Slips; Microsoft Ups Battle For Activision; Taiwan Semi To Build Second Chip Fab To Supply Apple, AMD, Nvidia
Major indexes fell slightly in the first hour of trading on Tuesday after Monday’s sell-off. The Dow Jones Industrial Average slipped 0.4% while the S&P 500 shed over 0.5% The tech-dominated Nasdaq showed the most downside, dropping more than 1%.
X
The Russell 2000 fell, though not as steeply as the Nasdaq, and was down nearly 0.5% in late morning trading.
Volume was lower on the NYSE and higher on the Nasdaq compared to the same time on Monday.
Crude oil continued its decline, albeit at a slower pace, and traded at $76.52 per barrel.
The yield on the benchmark 10-year Treasury note fell 2 basis points to 3.57%.
Stocks On Watch Today
Dow Jones leader Microsoft (MSFT) is pushing against antitrust laws in its $69 billion plans for acquiring Activision Blizzard (ATVI). Activision’s popular Call of Duty game will be available on Sony‘s (SONY) PlayStation for 10 years if the deal goes through. MSFT is down nearly 3% today.
Morgan Stanley analyst Betty Graseck upgraded JPMorgan (JPM) to buy with a price target of $153. Nonetheless, the Dow Jones component fell 2% in early trading.
Oppenheimer ‘s Christopher Glynn upgraded General Electric (GE) to outperform with a $104 price target. GE fell nearly 1%.
AbbVie (ABBV) is collaborating with Hotspot Therapeutics to license its discovery-stage IRF5 drug to treat autoimmune diseases. Shares are building a cup base with a buy point of 196.01.
TSMC (TSM) plans on a second chip plant in Arizona. The chip leader will increase its total investment in Arizona from $12 billion to $40 billion, following August’s CHIPS and Science Act, which includes incentives.
According to reports, Apple (AAPL), Advanced Micro Devices (AMD) and Nvidia (NVDA) will be the first to buy U.S.-made chips, starting in 2024.
Shares have fallen 2% today.
Royal Caribbean (RCL) is down over 4% after JPMorgan analyst Daniel Adam downgraded the stock to underweight with a price target of $47.
BioVie (BIVI) plunged 17% even though its Phase 2 trial appeared to have a positive effect on biomarkers of age-related diseases, such as dementia and other neurodegenerative conditions.
Mirati Therapeutics (MRTX) plunged over 20% even though preliminary results showed favorable response to the non-chemotherapy regimen in non small cell lung cancer patients with certain types of mutation. Investors questioned whether Mirati’s drug can take on traditional chemotherapy.
Outside Dow Jones: Earnings On Deck
AutoZone (AZO) fell after earnings early Tuesday. Sales grew 9% to $5.3 billion while earnings of $40.51 per share were 17% higher than the same quarter last year. Gitlab‘s (GTLB) third quarter sales of $113 million grew 69% while a loss of 10 cents per share was less than the 16 cents loss in Q3 of 2021. AZO is down 3% while GTLB is surging over 8%.
Costco (COST), GameStop (GME) and Campbell Soup (CPB) report on Wednesday. On Thursday , Lululemon (LULU) and Broadcom (AVGO) are on tap.
Shares of Costco have fallen below the 50-day line after the wholesale giant lowered its outlook last week. Meme stock GME has also fallen below its 50-day line ahead of earnings. CPB is up by 0.5% and remains above its 50-day line. LULU shed nearly 2% on strong volume in early action. AVGO is testing its 200-day line today.
Please follow VRamakrishnan @IBD_VRamakrishnan for more news on the stock market today.
YOU MAY ALSO LIKE:
Top Growth Stocks To Buy And Watch
Learn How To Time The Market With IBD’s ETF Market Strategy
Find The Best Long-Term Investments With IBD Long-Term Leaders
MarketSmith: Research, Charts, Data And Coaching All In One Place
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
